C26H20ClFN2O2
Neat
446.91
Brilanestrant; 1365888-06-7; GDC-0810; ARN-810; 9MM2R1A06R; RG-6046; DTXSID701336037; brilanestrantum; (2E)-3-{4-[(1E)-2-(2-CHLORO-4-FLUOROPHENYL)-1-(1H-INDAZOL-5-YL)BUT-1-EN-1-YL]PHENYL}PROP-2-ENOIC ACID; RefChem:917568; SERD ARN-810; DTXCID901766125; (2E)-3-(4-((1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)prop-2-enoic acid; RO7056118; (E)-3-(4-((E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid; Brilanestrant [USAN]; GDC 0810; GDC0810; UNII-9MM2R1A06R; CHEMBL3581693
(E)-3-[4-[(E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-enyl]phenyl]prop-2-enoic acid
InChI=1S/C26H20ClFN2O2/c1-2-21(22-10-9-20(28)14-23(22)27)26(18-8-11-24-19(13-18)15-29-30-24)17-6-3-16(4-7-17)5-12-25(31)32/h3-15H,2H2,1H3,(H,29,30)(H,31,32)/b12-5+,26-21+